FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
SPARC
201234567895012345678910123456789.8012345678950123456789
+2.10 (+0.84%)
1D
5D
1M
3M
1Y
5Y
Popular Posts
❮
❯
StockTradeX
Cambist Analytics
9amPrime
Aziz Khan
TradeAdda
Super Growth
Stocks in the news
Tata Consumer Products: The company will replace GAIL India in Nifty50 Index from March 31, 2021.
Pfizer: Brazil approved Pfizer's COVID vaccine for widespread use.
Sanofi India: The company approved a final dividend of Rs 125 per share and a special dividend of Rs 240 per share.
NTPC: The company executed a share purchase agreement with GAIL, to buy GAIL's 25.51 percent shareholding in Ratnagiri Gas and to exit from Konkan LNG.
SPARC: US FDA sought a new phase-3 study on cancer drug Taclantis.
Mazagon Dock: The company signed MoU with Mumbai Port Trust in Maritime India Summit 2021.
#SPARC #MAZDOCK #NTPC #TATACONSUM
TradeAdda
#SPARC BTST - ONCE EXIT LONG IN SPARC AT 194. BOOK PROFIT RS. 8000
Billion Club
Daily Stock Insight
TradeAdda
Great Eagle Capital
SPARC AROUND 146,, ONCE IT SUSTAINS FOR 15 TO 20 MINS BUY THIS ROCKET,,,,
#SPARC
A
aaaaa
Add a comment
Reputation: 27,898 • Nov 9 4:38 AM
Like
Comment
Share
Add a comment
Reputation: 27,898 • Nov 7 12:18 PM
Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?
Poly Medicure rose 5 percent to Rs 952.5 and formed big bullish candlestick pattern on the daily charts with strong volumes. In fact, it has seen a breakout of downward sloping resistance trend line adjoining several points from the October high.
Moneycontrol
Like
Comment
Share
Add a comment
Reputation: 27,898 • Nov 2 12:43 PM
Buy Sun Pharma; target of Rs 1240: Motilal Oswal
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 02, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
Reputation: 27,898 • Nov 2 6:13 AM
Sun Pharma’s specialty drugs bet is beginning to pay off
Sun Pharmaceutical’s foray into specialty drugs was in some ways driven by an existential threat posed by rising competition to its generic drug business in the US. In the September quarter, it reported sales of $200 million from specialty drugs in the US, up 27.5 percent YoY
Moneycontrol
Like
Comment
Share
Add a comment
Reputation: 27,898 • Oct 31 11:48 AM
Hot Stocks | Here's why you should bet on Sun Pharma Advanced Research, Jubilant Pharmova for short term
SPARC has witnessed a consolidation breakout on the back of robust volumes and surged above all its major EMAs (exponential moving averages) on the daily time frame. Simultaneously, in the last couple of sessions, strong traction has been seen in the overall sector.
Moneycontrol
Like
Comment
Share
Add a comment
Add a comment
Reputation: 27,898 • Sep 30 1:21 AM
Big Movers on D-St: What should investors do with Cipla, Asian Paints and SPARC?
Stocks that were in focus included names like Cipla, which was up nearly 2 per cent, Asian Paints, which fell more than 5 per cent, and Sun Pharma Advanced Research Company, which rallied by more than 15 per cent on Thursday.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Aug 8 1:03 AM
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jun 17 2:11 AM
Big Movers on D-St: What should investors do with SPARC, Delta Corp and M&M?
Stocks that were in focus on Thursday included names like Sun Pharma Advanced Research Company (SPARC) which fell more than 8 per cent, Delta Corp which was down over 7 per cent, and M&M which lost nearly 2 per cent.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 20,221 • May 15 12:30 PM
#SPARC will declare results on May 17, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Reputation: 5,127 • Feb 2 3:00 AM
Breakoutcharts DAY in SPARC#SPARC #breakout tgt done
Like
Comment
Share
Add a comment
Reputation: 20,221 • Feb 2 12:30 PM
#SPARC will declare results on Feb 4, 2022
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Add a comment
Reputation: 27,898 • Jan 21 2:36 AM
Buy Sun Pharma Advanced Research Company, target price Rs 345: Yes Securities
Time period given by analyst is Intra Day when Sun Pharma Advanced Research Company Ltd. price can reach defined target.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jan 20 12:31 PM
Day Trading Guide: 2 stock recommendations for Friday
Going ahead, a sustained trade above 17,800 will trigger a short-covering rally taking Nifty50 higher to levels of 17,900-18,000.
The Economic Times
Like
Comment
Share
Add a comment
Add a comment
Reputation: 27,898 • Dec 3, 2021 9:16 AM
SPARC enters licensing pact with Biomodifying for licensing of novel drug targets against cancer
“This is an important milestone for SPARC. The licensing of antibodies from Biomodifying will assist us in our endeavour to transition SPARC into a company focussed on novel treatment modalities, including bi-specific antibodies and antibody drug conjugates" said Anil Raghavan, CEO of SPARC.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 1,682 • Oct 31, 2021 5:46 AM
*SPARC* formed a Bullish BAT harmonic pattern on daily chart dated 29-10-2021 is considered a very bullish signal, Oscillators like Stochastic etc are in oversold zone. It can be traded long as ....
🟢Buy range @260-240, Target🎯280-300 Stop🏃Close < 230
3 Likes
Comment
Share
Add a comment
Reputation: 20,221 • Oct 30, 2021 12:30 PM
#SPARC will declare results on Nov 1, 2021
Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.
Like
Comment
Share
Add a comment
Add a comment
Reputation: 27,898 • Oct 1, 2021 1:11 AM
Stocks in the news: Paras Defence, HDFC Bank, ZEEL, Adani Green and NMDC
Paras Defence and Space Technologies will be listed today. The manufacturer of defence and space engineering products is expected to make a super solid Dalal street debut.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Sep 2, 2021 1:01 AM
Stocks in the news: Hero MotoCorp, Coal India, SBI, Vedanta and NMDC
Hero Motocorp reported 22 per cent dip in total sales at 4,53,879 units in August as compared with same month last year.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Sep 2, 2021 5:46 AM
SPARC seeks shareholders nod to raise up to Rs 1,800 cr
The approval is being sought for raising funds for an aggregate consideration of up to Rs 1,800 crore or in equivalent foreign currency, SPARC said.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Aug 20, 2021 9:36 AM
Ackman seeks SPAC relaunch to fix lawsuit's 'harm'
The lawsuit, filed by former US Securities and Exchange Commissioner Robert Jackson and others on behalf of a Tontine shareholder, argues that Ackman's special purpose acquisition company (SPAC) - the largest ever formed - broke the law by investing in securities while not properly registered with regulators.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 10,198 • Aug 18, 2021 1:10 AM
Target 1 (17%) achieved in SPARC. Target 2 is ON... for NSE:SPARC by MandeepSinghKohli
This is follow-up on Sun Pharma Advanced Research Company (SPARC). Can check link to related ideas.
Target 1 achieved. More than 17%. Target 2 is ON.
Chart is self explanatory. Entry, Targets and Trailing Stop Loss are mentioned on the chart.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
TradingView
1 Like
Comment
Share
Add a comment
Reputation: 27,898 • Aug 17, 2021 2:36 AM
Buy Sun Pharma Advanced Research Company, target price Rs 325: Yes Securities
Sun Pharma Advanced Research Company Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7865.36 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Aug 5, 2021 3:26 AM
Ahead of Market: 12 things that will decide stock action on Friday
Mazhar Mohammad at Chartviewindia.in said it is critical for the Nifty to sustain above 16,210 to retain positive bias.
The Economic Times
Like
Comment
Share
Add a comment
Add a comment
Reputation: 27,898 • Aug 1, 2021 10:36 AM
Ahead of Market: 12 things that will decide stock action on Monday
Gaurav Ratnaparkhi of Sharekhan said Nifty50 may see a brief consolidation near the 15,700-15,850 range before heading towards the 16,000 level on the upside. Mazhar Mohammad of Chartviewindia.in said the 15,900-600 trading range may continue for some time. "The monthly charts have registered two back-to-back indecisive candle formations with a narrow range of 450 points, hinting at pausing momentum,” he said. Heres a look at what some of the key indicators are suggesting for Monday's action:
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jul 30, 2021 10:21 AM
Biggest gainers & losers of the day: Privi Speciality gains 20%, Swan Energy sheds 16%
Investors have started booking profits in recent gainers as markets have turned indecisive. However, IT, pharma and chemical sectors continued to attract investors.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jul 27, 2021 3:41 AM
Ahead of Market: 12 things that will decide stock action on Wednesday
Mazhar Mohammad of Chartviewindia.in said a major downswing is unlikely as long as the index holds above the 15,600 level.
The Economic Times
Like
Comment
Share
Add a comment
Add a comment
Reputation: 1,125 • Jul 26, 2021 3:31 AM
#SPARC looks to good for fresh buy /pyramiding above 265,
The weekly charts are showing higher high for about few weeks and the daily charts are showing similar moves
The volume support has been steady in the recent past , The counter has making highers highs for while now ......read more
Like
Comment
Share
Add a comment
Reputation: 6,012 • Jul 25, 2021 2:45 AM
#SPARC BO around 205 T of 270 Hit ,Around 205 Triangular Wave formed and Breakout I think, Anyway Accumulation going for many months.
Buy around 258 SL 246-48 Target 275,283.
3 Likes
1 Comment
Share
Add a comment
Add a comment
Reputation: 607 • Jul 25, 2021 10:01 AM
PowerTrader#MY WATCHLIST FOR 26-07-2021
ADDED
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jul 25, 2021 9:56 AM
Ahead of Market: 12 things that will decide stock action on Monday
Mazhar Mohammad of Chartviewindia.in said crossing the 15,900 level can give much-needed confidence to the bulls who can get the courage to march towards 16,300 levels.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 10,198 • Jul 24, 2021 10:30 AM
Breakout in Sun Pharma Advanced Research Company (SPARC)... for NSE:SPARC by MandeepSinghKohli
Chart is self explanatory. Entry, Targets and Stop Loss are mentioned on the chart.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
TradingView
Chart is self explanatory. Entry, Targets and Stop Loss are mentioned on the chart.
2 Likes
Comment
Share
Add a comment
Add a comment
Add a comment
Reputation: 27,898 • Jul 21, 2021 1:46 AM
Ahead of Market: 12 things that will decide stock action on Thursday
Analysts said a fall below the crucial support of 15,630-15,600 can open up the doors for the index to hit the 15,450 level.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jul 8, 2021 3:51 AM
Ahead of Market: 12 things that will decide stock action on Friday
Mazhar Mohammad at Chartviewindia.in said Nifty needs to sustain above the 15,680 level on Friday, as a close below that level could strengthen the bearish sentiments further.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jul 8, 2021 7:16 AM
SPARC raises over Rs 1,110 cr; issues warrants to promoter Dilip Shanghvi, others
The issue price includes the warrant subscription price (Rs. 44.50 per warrant) and the warrant exercise price (Rs. 133.50 per warrant).
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 23,395 • Jul 7, 2021 2:40 AM
Premium Analysis Club service by The Intraday Trader
In this service you will get following:-1) Daily precise Levels for NIFTY and BANKNIFTY for entry and exit Both in FnO2) Stock Analysis for Swing and Positional Trading3) Weekly NIFTY Sectoral Analysis4) Study Material (Books and PDFs)5) LIVE MARKET
FrontPage
#SPARC shared by us on our Premium Channel see now where it is
Join our Premium Channel and avail the benefits of it
Currently 50% off use Coupon Code PREMIUM50 to apply the code and get 50% off
Offer is valid for a limited period only
1 Like
Comment
Share
Add a comment
Reputation: 27,898 • Jun 15, 2021 2:56 AM
Ahead of Market: 12 things that will decide stock action on Wednesday
Nifty moved in a tight range of 59 points throughout the day and formed a 'Doji' candle on the daily chart, suggesting indecisiveness among traders.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 775 • Jun 13, 2021 6:59 AM
Super Growth in SPARC#SPARC WEEKLY CHART
#SPARC MADE HIGH OF 264 HOLD FIR 300+ TARGETS OR TRAIL SL AT COST
Like
Comment
Share
Add a comment
Reputation: 412 • Jun 11, 2021 6:32 AM
ChartArt in SPARC#SPARC CMP 232.5 Activation Key - It should ...
#SPARC | Target Achieved
Boooooommmmmm Target given as 264 which was achieved on 06/09, Made a high of 264.90
Like
Comment
Share
Add a comment
Reputation: 27,898 • Jun 9, 2021 3:11 AM
Ahead of Market: 12 things that will decide stock action on Thursday
Sensex slipped below the 52,000 mark, while Nifty ended below the crucial 15,550 level.
The Economic Times
Like
Comment
Share
Add a comment
Reputation: 55,057 • Jun 9, 2021 6:36 AM
TradeAdda in SPARC#SPARC For Educational Purpose Only #TradeAdda
SPARC
#Update
Retest Done Bought 215 and again 240/220 now Fresh high 256 Looks set for 300+ Keep Trailing
2 Likes
Comment
Share
Add a comment